NeuroSense Updates on Compliance Status with Nasdaq Listing Requirements#USA#Cambridge#biotechnology#NeuroSense#NRSN
NeuroSense Updates on Compliance Status with Nasdaq Listing Requirements
NeuroSense Therapeutics has provided important updates on its progress with Nasdaq's listing requirements and future plans for compliance.
third-news.com
October 2, 2026 at 8:29 PM
NeuroSense Updates on Compliance Status with Nasdaq Listing Requirements#USA#Cambridge#biotechnology#NeuroSense#NRSN
#NRSN NeuroSense Provides Update on Nasdaq Listing Compliance
https://www.stocktitan.net/news/NRSN/neuro-sense-provides-update-on-nasdaq-listing-jv33ygyny5ye.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/NRSN/neuro-sense-provides-update-on-nasdaq-listing-jv33ygyny5ye.html?utm_source=stocktitan-bluesky&utm_medium=social
NeuroSense Provides Update on Nasdaq Listing Compliance
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
October 2, 2026 at 8:15 PM
#NRSN NeuroSense Provides Update on Nasdaq Listing Compliance
https://www.stocktitan.net/news/NRSN/neuro-sense-provides-update-on-nasdaq-listing-jv33ygyny5ye.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/NRSN/neuro-sense-provides-update-on-nasdaq-listing-jv33ygyny5ye.html?utm_source=stocktitan-bluesky&utm_medium=social
Trading Resumed for $NRSN NeuroSense Thera Ltd Ord | at 09:51:45 ET on NASDAQ | 2026-09-30
September 30, 2026 at 1:58 PM
Trading Resumed for $NRSN NeuroSense Thera Ltd Ord | at 09:51:45 ET on NASDAQ | 2026-09-30
Trading Halted for $NRSN NeuroSense Thera Ltd Ord | at 09:46:45.486 ET on NASDAQ | Volatility Trading Pause | 2026-09-30
September 30, 2026 at 1:48 PM
Trading Halted for $NRSN NeuroSense Thera Ltd Ord | at 09:46:45.486 ET on NASDAQ | Volatility Trading Pause | 2026-09-30
NeuroSense Therapeutics to Showcase Innovations at the 5th Annual ROTH Healthcare Opportunities Conference#United_States#New_York#ALS#NeuroSense#PrimeC
NeuroSense Therapeutics to Showcase Innovations at the 5th Annual ROTH Healthcare Opportunities Conference
NeuroSense Therapeutics is set to participate in the 5th Annual ROTH Healthcare Opportunities Conference, discussing key advancements in neurodegenerative disease treatments.
third-news.com
September 28, 2026 at 4:46 PM
NeuroSense Therapeutics to Showcase Innovations at the 5th Annual ROTH Healthcare Opportunities Conference#United_States#New_York#ALS#NeuroSense#PrimeC
#NRSN NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
https://www.stocktitan.net/news/NRSN/neuro-sense-to-participate-in-the-5th-annual-roth-healthcare-2rrh862r668i.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/NRSN/neuro-sense-to-participate-in-the-5th-annual-roth-healthcare-2rrh862r668i.html?utm_source=stocktitan-bluesky&utm_medium=social
NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
NeuroSense Therapeutics (NRSN) Chief Financial Officer Or Eisenberg will attend the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026.He will meet with institutional investors in New York City. Expected topics include clinical and regulatory progress with PrimeC, its ALS drug candidate, and the company’s strategy toward potential regulatory approval in Canada, the U.S. and other markets.
www.stocktitan.net
September 28, 2026 at 4:43 PM
#NRSN NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
https://www.stocktitan.net/news/NRSN/neuro-sense-to-participate-in-the-5th-annual-roth-healthcare-2rrh862r668i.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/NRSN/neuro-sense-to-participate-in-the-5th-annual-roth-healthcare-2rrh862r668i.html?utm_source=stocktitan-bluesky&utm_medium=social
NeuroSense's Strategies and Financial Results for the First Half of 2026#United_States#Cambridge#ALS#NeuroSense#PrimeC
NeuroSense's Strategies and Financial Results for the First Half of 2026
NeuroSense Therapeutics provides a comprehensive update on its strategic initiatives and financial outcomes for the first half of 2026, highlighting progress with its ALS therapy, PrimeC.
third-news.com
September 25, 2026 at 8:36 PM
NeuroSense's Strategies and Financial Results for the First Half of 2026#United_States#Cambridge#ALS#NeuroSense#PrimeC
#NRSN NeuroSense Provides Business Update and Progress for the First Half of 2026
https://www.stocktitan.net/news/NRSN/neuro-sense-provides-business-update-and-progress-for-the-first-half-il726kwsuy96.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/NRSN/neuro-sense-provides-business-update-and-progress-for-the-first-half-il726kwsuy96.html?utm_source=stocktitan-bluesky&utm_medium=social
NeuroSense Provides Business Update and Progress for the First Half of 2026
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
September 25, 2026 at 8:30 PM
#NRSN NeuroSense Provides Business Update and Progress for the First Half of 2026
https://www.stocktitan.net/news/NRSN/neuro-sense-provides-business-update-and-progress-for-the-first-half-il726kwsuy96.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/NRSN/neuro-sense-provides-business-update-and-progress-for-the-first-half-il726kwsuy96.html?utm_source=stocktitan-bluesky&utm_medium=social
NeuroSense splits one big ALS trial into three longevity.technology/news/neurose... via @instapaper.com
longevity.technology
September 18, 2026 at 1:06 PM
NeuroSense splits one big ALS trial into three longevity.technology/news/neurose... via @instapaper.com
Trading Halted for $NRSNW NeuroSense Thera Ltd Wt | at 19:50:00.000 ET on NASDAQ | Halt - News Pending | 2026-09-11
September 11, 2026 at 11:51 PM
Trading Halted for $NRSNW NeuroSense Thera Ltd Wt | at 19:50:00.000 ET on NASDAQ | Halt - News Pending | 2026-09-11
Trading Halted for $NRSN NeuroSense Thera Ltd Ord | at 19:50:00.000 ET on NASDAQ | Halt - News Pending | 2026-09-11
September 11, 2026 at 11:51 PM
Trading Halted for $NRSN NeuroSense Thera Ltd Ord | at 19:50:00.000 ET on NASDAQ | Halt - News Pending | 2026-09-11
@drdeanburnett.bsky.social have you ever come across this podcast: neurosense.substack.com - I started listening because of previous content by the author re school non-attendance which had been recommended to me, but I'm finding the approach to neurodivergence from psychologists hard to take.
Let's Talk Neurosense: the psychology of neurodiversity | Dr Naomi Fisher | Substack
The place for the really important conversations about neurodiversity. Click to read Let's Talk Neurosense: the psychology of neurodiversity, a Substack publication with thousands of subscribers.
neurosense.substack.com
September 10, 2026 at 5:54 PM
@drdeanburnett.bsky.social have you ever come across this podcast: neurosense.substack.com - I started listening because of previous content by the author re school non-attendance which had been recommended to me, but I'm finding the approach to neurodivergence from psychologists hard to take.
NeuroSense's Participation at the 28th Annual H.C. Wainwright Global Investment Conference#United_States#New_York#Conference#ALS#NeuroSense
NeuroSense's Participation at the 28th Annual H.C. Wainwright Global Investment Conference
NeuroSense Therapeutics is set to present at the H.C. Wainwright 28th Annual Global Investment Conference. The company will highlight its advancements in ALS treatment.
third-news.com
September 10, 2026 at 1:30 PM
NeuroSense's Participation at the 28th Annual H.C. Wainwright Global Investment Conference#United_States#New_York#Conference#ALS#NeuroSense
#NRSN NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference
https://www.stocktitan.net/news/NRSN/neuro-sense-to-present-at-h-c-wainwright-28th-annual-global-8wlq7xcdtk7f.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/NRSN/neuro-sense-to-present-at-h-c-wainwright-28th-annual-global-8wlq7xcdtk7f.html?utm_source=stocktitan-bluesky&utm_medium=social
NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
September 10, 2026 at 1:00 PM
#NRSN NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference
https://www.stocktitan.net/news/NRSN/neuro-sense-to-present-at-h-c-wainwright-28th-annual-global-8wlq7xcdtk7f.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/NRSN/neuro-sense-to-present-at-h-c-wainwright-28th-annual-global-8wlq7xcdtk7f.html?utm_source=stocktitan-bluesky&utm_medium=social
Explore the details: https://bit.ly/3UyUQQz
Neurosense Therapeutics is revamping its development plan for PrimeC, an experimental oral treatment for amyotrophic lateral sclerosis (ALS).
#ALS #ALSNewsToday #Bionews #ALSCommunity
Neurosense Therapeutics is revamping its development plan for PrimeC, an experimental oral treatment for amyotrophic lateral sclerosis (ALS).
#ALS #ALSNewsToday #Bionews #ALSCommunity
Revamped plan aims to hasten US approval of treatment for ALS
Neurosense Therapeutics is revamping its development plan for PrimeC, an experimental oral treatment for amyotrophic lateral sclerosis (ALS).
bit.ly
September 2, 2026 at 5:37 PM
Explore the details: https://bit.ly/3UyUQQz
Neurosense Therapeutics is revamping its development plan for PrimeC, an experimental oral treatment for amyotrophic lateral sclerosis (ALS).
#ALS #ALSNewsToday #Bionews #ALSCommunity
Neurosense Therapeutics is revamping its development plan for PrimeC, an experimental oral treatment for amyotrophic lateral sclerosis (ALS).
#ALS #ALSNewsToday #Bionews #ALSCommunity
NeuroSense Develops Fast-Track Strategy for PrimeC's ALS Approval Process#USA#Cambridge#ALS#NeuroSense#PrimeC
NeuroSense Develops Fast-Track Strategy for PrimeC's ALS Approval Process
NeuroSense Therapeutics announces a revised strategy to accelerate PrimeC's path to potential ALS approval while controlling costs. This innovative approach includes AI analysis and comparative trials.
third-news.com
August 31, 2026 at 12:50 PM
NeuroSense Develops Fast-Track Strategy for PrimeC's ALS Approval Process#USA#Cambridge#ALS#NeuroSense#PrimeC
#NRSN NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS
https://www.stocktitan.net/news/NRSN/neuro-sense-unveils-accelerated-capital-efficient-strategy-to-oq0v630ua1ru.html
https://www.stocktitan.net/news/NRSN/neuro-sense-unveils-accelerated-capital-efficient-strategy-to-oq0v630ua1ru.html
NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
August 31, 2026 at 12:45 PM
#NRSN NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS
https://www.stocktitan.net/news/NRSN/neuro-sense-unveils-accelerated-capital-efficient-strategy-to-oq0v630ua1ru.html
https://www.stocktitan.net/news/NRSN/neuro-sense-unveils-accelerated-capital-efficient-strategy-to-oq0v630ua1ru.html
Excellent podcast discussing what the Guardian has called the most controversial show of the year - Channel 4's 'The Great AHDH Myth:
podcasts.apple.com/gb/podcast/b...
podcasts.apple.com/gb/podcast/b...
BONUS: The Great ADHD Myth? with Lucy Johnstone
Podcast Episode · Let's Talk Neurosense: the psychology of neurodiversity · S2 Bonus · 1hr 8min
podcasts.apple.com
August 20, 2026 at 6:18 PM
Excellent podcast discussing what the Guardian has called the most controversial show of the year - Channel 4's 'The Great AHDH Myth:
podcasts.apple.com/gb/podcast/b...
podcasts.apple.com/gb/podcast/b...
A reflection on the reactions to ‘The Great ADHD Myth’ documentary. Naomi Fisher and Dani Drinkwater talk to Dr Lucy Johnstone
podcasts.apple.com/gb/podcast/b...
podcasts.apple.com/gb/podcast/b...
BONUS: The Great ADHD Myth? with Lucy Johnstone
Podcast Episode · Let's Talk Neurosense: the psychology of neurodiversity · S2 Bonus · 1hr 8min
podcasts.apple.com
August 20, 2026 at 11:46 AM
A reflection on the reactions to ‘The Great ADHD Myth’ documentary. Naomi Fisher and Dani Drinkwater talk to Dr Lucy Johnstone
podcasts.apple.com/gb/podcast/b...
podcasts.apple.com/gb/podcast/b...
NeuroSense Therapeutics Updates Shareholders on PrimeC Progress and Future Plans#USA#Cambridge#ALS#NeuroSense#PrimeC
NeuroSense Therapeutics Updates Shareholders on PrimeC Progress and Future Plans
NeuroSense Therapeutics shares critical updates on their Phase 3 PARAGON study for ALS, regulatory opportunities, and financial strategy to shareholders.
third-news.com
August 13, 2026 at 1:49 PM
NeuroSense Therapeutics Updates Shareholders on PrimeC Progress and Future Plans#USA#Cambridge#ALS#NeuroSense#PrimeC